The Surge In Demand For Personalized Medicine Boosts The Whole Genome And Exome Sequencing Market Driver: Leading Transformation in the Whole Genome And Exome Sequencing Market in 2025

What Are the Projected Growth and Market Size Trends for the Whole Genome And Exome Sequencing Market?
The market size for whole genome and exome sequencing has experienced a significant expansion in the past few years. Projected to rise from $2.02 billion in 2024, it will reach $2.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 24.8%. The augmentation during the historic period is due to factors such as reducing sequencing costs, increased prevalence of genetic disorders, clinical applications, the availability of genomic data repositories, and advancements in the field of bioinformatics.

Over the next years, we will witness a surge in the size of the whole genome and exome sequencing market, as it is projected to rise to a remarkable $6.14 billion in 2029, showing a compound annual growth rate (CAGR) of 24.9%. Various factors underpinning this anticipated growth during the specified forecast period include population genomics initiatives, heightened demand for precision medicine, progress in single-cell sequencing, increased use of non-invasive prenatal testing (NIPT), and usage in the investigation of rare diseases. Key trends that will mark the forecast period encompass broader clinical adoption, swift progress in sequencing technologies, the emergence of population-scale genomic studies, and the integration of artificial intelligence (AI) and machine learning (ML), as well as growing applications in oncology.

What Is Driving the Growth Trajectory of the Whole Genome And Exome Sequencing Market?
The whole genome and exome sequencing market is predicted to grow due to the increasing need for personalized medicine. Personalized medicine customizes health decisions and medical interventions based on the individual characteristics of each patient, including genetics, surroundings, and lifestyle. Whole genome and exome sequencing tools aid in this process by providing an extensive analysis of a person's genetic information. This abundance of information helps in customizing health decisions and interventions according to a person's unique genetics, environment, and lifestyle. For example, the Personalized Medicine Coalition (PMC), a US-based organization advocating the understanding and implementation of personalized medicine, reported in October 2022 that more than 75,000 genetic testing products along with 300 personalized medicines are foreseen to be available in the market in 2022. Additionally, the Center for Drug Evaluation and Research (CDER) under the Food and Drug Administration has approved 37 new molecular entities (NMEs) in 2022. Within the 35 therapeutic NMEs, approximately 12, which represent 34%, are categorized as personalized. Therefore, the increasing demand for personalized medicine fuels the growth of the whole genome and exome sequencing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

Which Leading Companies Are Shaping the Growth of the Whole Genome And Exome Sequencing Market?
Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

What Are the Major Trends Shaping the Whole Genome And Exome Sequencing Market?
Essential businesses in the whole genome and exome sequencing industry are putting more emphasis on the production of cutting-edge tech solutions,including ultra-fast NGS (next-generation sequencing) analysis, to secure a competitive position in the market. Ultra-fast NGS analysis, a tech breakthrough, enables the handling of next-generation sequencing (NGS) data at an incredibly fast pace, substantially decreasing the duration required for genomic data analysis. To illustrate, QIAGEN Digital Insights (QDI), a bioinformatics firm based in the US, unveiled its ultra-fast NGS analysis platform in January 2023. The platform includes features such as the ability to process an entire genome in 25 minutes at a cost of $1 in cloud computing charges, which enhances efficiency, cost-effectiveness, and scalability. This tech advance significantly accelerates the speed and accessibility of genomic data analysis, thus holding substantial significance in the whole genome and exome sequencing market by facilitating rapid decision processes and broader acceptance of personalized medicine.

What Are the Key Segments of the Whole Genome And Exome Sequencing Market?
The whole genome and exome sequencing market covered in this report is segmented -

1) By Product Type: Kits, Instruments
2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications
4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:
1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits
2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Which Region Dominates the Whole Genome And Exome Sequencing Market?
North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Whole Genome And Exome Sequencing Global Market Report?

- Market Size Analysis: Analyze the Whole Genome And Exome Sequencing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Whole Genome And Exome Sequencing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Whole Genome And Exome Sequencing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Whole Genome And Exome Sequencing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.